The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples